puri-nethol 50mg tablets
mawdsley-brooks & company ltd - mercaptopurine - oral tablet - 50mg
puri-nethol 50mg tablets
sigma pharmaceuticals plc - mercaptopurine - oral tablet - 50mg
puri-nethol 50mg tablets
necessity supplies ltd - mercaptopurine - oral tablet - 50mg
puri-nethol 50mg tablets
de pharmaceuticals - mercaptopurine - oral tablet - 50mg
puri-nethol 50mg tablets
pilsco ltd - mercaptopurine - oral tablet - 50mg
puri-nethol 50mg tablets
aspen pharma trading ltd - mercaptopurine - oral tablet - 50mg
puri-nethol mercaptopurine monohydrate 50mg tablet bottle
aspen pharmacare australia pty ltd - mercaptopurine monohydrate, quantity: 50 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; stearic acid; magnesium stearate; hydrolysed maize starch - indications as at 5 march 2004: treatment of leukemia. it is of value in remission induction and is particularly indicated for maintenance therapy in acute lymphoblastic leukemia and acute myelogenous leukemia. puri-nethol is also used in the treatment of chronic granulocytic leukaemia.
puri-nethol 50 mg tablet
pi pharma - mercaptopurine - tablet - 50 mg - mercaptopurine 50 mg - mercaptopurine
puri-nethol tablets 50 mg
padagis israel agencies ltd, israel - mercaptopurine - tablets - mercaptopurine 50 mg - mercaptopurine - mercaptopurine - for the treatment of acute leukemia and also in cases of chronic myelogenous leukemia.
puri-nethol 50 mg tabl.
aspen pharma trading ltd. - mercaptopurine 50 mg - tablet - 50 mg - mercaptopurine 50 mg - mercaptopurine